197 related articles for article (PubMed ID: 38461154)
1. FUS unveiled in mitochondrial DNA repair and targeted ligase-1 expression rescues repair-defects in FUS-linked motor neuron disease.
Kodavati M; Wang H; Guo W; Mitra J; Hegde PM; Provasek V; Rao VHM; Vedula I; Zhang A; Mitra S; Tomkinson AE; Hamilton DJ; Van Den Bosch L; Hegde ML
Nat Commun; 2024 Mar; 15(1):2156. PubMed ID: 38461154
[TBL] [Abstract][Full Text] [Related]
2. FUS Unveiled in Mitochondrial DNA Repair and Targeted Ligase-1 Expression Rescues Repair-Defects in FUS-Linked Neurodegeneration.
Kodavati M; Wang H; Guo W; Mitra J; Hegde PM; Provasek V; Maloji Rao VH; Vedula I; Zhang A; Mitra S; Tomkinson AE; Hamilton DJ; Bosch LVD; Hegde ML
Res Sq; 2023 Jul; ():. PubMed ID: 37502965
[TBL] [Abstract][Full Text] [Related]
3. RT
Wang H; Rangaswamy S; Kodavati M; Mitra J; Guo W; Guerrero EN; Van Den Bosch L; Hegde ML
Mol Brain; 2019 Dec; 12(1):103. PubMed ID: 31801573
[TBL] [Abstract][Full Text] [Related]
4. Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
Pelaez MC; Desmeules A; Gelon PA; Glasson B; Marcadet L; Rodgers A; Phaneuf D; Pozzi S; Dutchak PA; Julien JP; Sephton CF
Acta Neuropathol Commun; 2023 Nov; 11(1):182. PubMed ID: 37974279
[TBL] [Abstract][Full Text] [Related]
5. Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis.
Wang H; Guo W; Mitra J; Hegde PM; Vandoorne T; Eckelmann BJ; Mitra S; Tomkinson AE; Van Den Bosch L; Hegde ML
Nat Commun; 2018 Sep; 9(1):3683. PubMed ID: 30206235
[TBL] [Abstract][Full Text] [Related]
6. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis.
Scekic-Zahirovic J; Oussini HE; Mersmann S; Drenner K; Wagner M; Sun Y; Allmeroth K; Dieterlé S; Sinniger J; Dirrig-Grosch S; René F; Dormann D; Haass C; Ludolph AC; Lagier-Tourenne C; Storkebaum E; Dupuis L
Acta Neuropathol; 2017 Jun; 133(6):887-906. PubMed ID: 28243725
[TBL] [Abstract][Full Text] [Related]
7. Dysfunction in nonsense-mediated decay, protein homeostasis, mitochondrial function, and brain connectivity in ALS-FUS mice with cognitive deficits.
Ho WY; Agrawal I; Tyan SH; Sanford E; Chang WT; Lim K; Ong J; Tan BSY; Moe AAK; Yu R; Wong P; Tucker-Kellogg G; Koo E; Chuang KH; Ling SC
Acta Neuropathol Commun; 2021 Jan; 9(1):9. PubMed ID: 33407930
[TBL] [Abstract][Full Text] [Related]
8. Vascular regression precedes motor neuron loss in the FUS (1-359) ALS mouse model.
Crivello M; Hogg MC; Jirström E; Halang L; Woods I; Rayner M; Coughlan KS; Lewandowski SA; Prehn JHM
Dis Model Mech; 2019 Aug; 12(8):. PubMed ID: 31383794
[TBL] [Abstract][Full Text] [Related]
9. Disruption of MAM integrity in mutant FUS oligodendroglial progenitors from hiPSCs.
Zhu Y; Burg T; Neyrinck K; Vervliet T; Nami F; Vervoort E; Ahuja K; Sassano ML; Chai YC; Tharkeshwar AK; De Smedt J; Hu H; Bultynck G; Agostinis P; Swinnen JV; Van Den Bosch L; da Costa RFM; Verfaillie C
Acta Neuropathol; 2024 Jan; 147(1):6. PubMed ID: 38170217
[TBL] [Abstract][Full Text] [Related]
10. Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations.
Finelli MJ; Liu KX; Wu Y; Oliver PL; Davies KE
Hum Mol Genet; 2015 Jun; 24(12):3529-44. PubMed ID: 25792726
[TBL] [Abstract][Full Text] [Related]
11. lncRNA Sequencing Reveals Neurodegeneration-Associated FUS Mutations Alter Transcriptional Landscape of iPS Cells That Persists in Motor Neurons.
Provasek VE; Kodavati M; Guo W; Wang H; Boldogh I; Van Den Bosch L; Britz G; Hegde ML
Cells; 2023 Oct; 12(20):. PubMed ID: 37887305
[TBL] [Abstract][Full Text] [Related]
12. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms.
Wächter N; Storch A; Hermann A
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):431-41. PubMed ID: 26174443
[TBL] [Abstract][Full Text] [Related]
13. ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay.
Kamelgarn M; Chen J; Kuang L; Jin H; Kasarskis EJ; Zhu H
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11904-E11913. PubMed ID: 30455313
[TBL] [Abstract][Full Text] [Related]
14. FUS interacts with nuclear matrix-associated protein SAFB1 as well as Matrin3 to regulate splicing and ligand-mediated transcription.
Yamaguchi A; Takanashi K
Sci Rep; 2016 Oct; 6():35195. PubMed ID: 27731383
[TBL] [Abstract][Full Text] [Related]
15. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR
Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723
[TBL] [Abstract][Full Text] [Related]
16. Amyotrophic Lateral Sclerosis, FUS and Protein Synthesis Defects.
Assoni AF; Foijer F; Zatz M
Stem Cell Rev Rep; 2023 Apr; 19(3):625-638. PubMed ID: 36515764
[TBL] [Abstract][Full Text] [Related]
17. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways.
Blokhuis AM; Koppers M; Groen EJN; van den Heuvel DMA; Dini Modigliani S; Anink JJ; Fumoto K; van Diggelen F; Snelting A; Sodaar P; Verheijen BM; Demmers JAA; Veldink JH; Aronica E; Bozzoni I; den Hertog J; van den Berg LH; Pasterkamp RJ
Acta Neuropathol; 2016 Aug; 132(2):175-196. PubMed ID: 27164932
[TBL] [Abstract][Full Text] [Related]
18. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.
Verbeeck C; Deng Q; Dejesus-Hernandez M; Taylor G; Ceballos-Diaz C; Kocerha J; Golde T; Das P; Rademakers R; Dickson DW; Kukar T
Mol Neurodegener; 2012 Oct; 7():53. PubMed ID: 23046583
[TBL] [Abstract][Full Text] [Related]
19. Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice.
Shelkovnikova TA; Peters OM; Deykin AV; Connor-Robson N; Robinson H; Ustyugov AA; Bachurin SO; Ermolkevich TG; Goldman IL; Sadchikova ER; Kovrazhkina EA; Skvortsova VI; Ling SC; Da Cruz S; Parone PA; Buchman VL; Ninkina NN
J Biol Chem; 2013 Aug; 288(35):25266-25274. PubMed ID: 23867462
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic modulation of GSTO activity rescues FUS-associated neurotoxicity via deglutathionylation in ALS disease models.
Cha SJ; Lee S; Choi HJ; Han YJ; Jeon YM; Jo M; Lee S; Nahm M; Lim SM; Kim SH; Kim HJ; Kim K
Dev Cell; 2022 Mar; 57(6):783-798.e8. PubMed ID: 35320731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
